Genotyping by Induced Förster Resonance Energy Transfer (iFRET) Mechanism and Simultaneous Mutation Scanning
暂无分享,去创建一个
A. Jakubowska | J. Lubiński | C. Cybulski | T. Dębniak | B. Górski | B. Masojć | T. van de Wetering | H. Rudnicka | Z. Dwight | K. Mȩdrek
[1] Jian Ye,et al. Primer-BLAST: A tool to design target-specific primers for polymerase chain reaction , 2012, BMC Bioinformatics.
[2] L. Kristensen,et al. Competitive amplification of differentially melting amplicons (CADMA) enables sensitive and direct detection of all mutation types by high‐resolution melting analysis , 2012, Human mutation.
[3] A. Hauschild,et al. Improved survival with vemurafenib in melanoma with BRAF V600E mutation. , 2011, The New England journal of medicine.
[4] Meiping Zhao,et al. Rapid and Sensitive Detection of KRAS Mutation After fast-COLD-PCR Enrichment and High-resolution Melting Analysis , 2011, Diagnostic molecular pathology : the American journal of surgical pathology, part B.
[5] Larissa V Furtado,et al. Frequency of KRAS, BRAF, and NRAS mutations in colorectal cancer , 2011, Genes, chromosomes & cancer.
[6] Carl T. Wittwer,et al. uMELT: prediction of high-resolution melting curves and dynamic melting profiles of PCR products in a rich web application , 2011, Bioinform..
[7] Mary Goldman,et al. The UCSC Genome Browser database: update 2011 , 2010, Nucleic Acids Res..
[8] Jin Li,et al. Ice-COLD-PCR enables rapid amplification and robust enrichment for low-abundance unknown DNA mutations , 2010, Nucleic Acids Res..
[9] F. Cianchi,et al. The use of COLD-PCR and high-resolution melting analysis improves the limit of detection of KRAS and BRAF mutations in colorectal cancer. , 2010, The Journal of molecular diagnostics : JMD.
[10] C. Wittwer,et al. Enrichment and detection of rare alleles by means of snapback primers and rapid-cycle PCR. , 2010, Clinical chemistry.
[11] J. Lubiński,et al. Pathologic complete response rates in young women with BRCA1-positive breast cancers after neoadjuvant chemotherapy. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[12] A. Bardelli,et al. Biomarkers Predicting Clinical Outcome of Epidermal Growth Factor Receptor–Targeted Therapy in Metastatic Colorectal Cancer , 2009, Journal of the National Cancer Institute.
[13] J. Kładny,et al. Response to neoadjuvant therapy with cisplatin in BRCA1-positive breast cancer patients , 2009, Breast Cancer Research and Treatment.
[14] R. Berbeco,et al. Replacing PCR with COLD-PCR enriches variant DNA sequences and redefines the sensitivity of genetic testing , 2008, Nature Medicine.
[15] M. Kolodney,et al. Selective amplification of rare mutations using locked nucleic acid oligonucleotides that competitively inhibit primer binding to wild-type DNA. , 2008, The Journal of investigative dermatology.
[16] K. Voelkerding,et al. Expanded instrument comparison of amplicon DNA melting analysis for mutation scanning and genotyping. , 2007, Clinical chemistry.
[17] T. Frebourg,et al. Clinical relevance of KRAS mutation detection in metastatic colorectal cancer treated by Cetuximab plus chemotherapy , 2007, British Journal of Cancer.
[18] A. Lièvre,et al. KRAS mutation status is predictive of response to cetuximab therapy in colorectal cancer. , 2006, Cancer research.
[19] P. Dominguez,et al. Wild-type blocking polymerase chain reaction for detection of single nucleotide minority mutations from clinical specimens , 2005, Oncogene.
[20] Robert Palais,et al. High-resolution DNA melting analysis for simultaneous mutation scanning and genotyping in solution. , 2005, Clinical chemistry.
[21] A. Jakubowska,et al. Breast cancer predisposing alleles in Poland , 2005, Breast Cancer Research and Treatment.
[22] H. Oettle,et al. Detection of Ki-ras mutations in tissue and plasma samples of patients with pancreatic cancer using PNA-mediated PCR clamping and hybridisation probes , 2005, British Journal of Cancer.
[23] D. Watson,et al. Genotyping with TaqMAMA. , 2004, Genomics.
[24] A. Brookes,et al. DASH-2: flexible, low-cost, and high-throughput SNP genotyping by dynamic allele-specific hybridization on membrane arrays. , 2003, Genome research.
[25] Yuri E Nikiforov,et al. High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma. , 2003, Cancer research.
[26] Magnus Jobs,et al. iFRET: an improved fluorescence system for DNA-melting analysis. , 2002, Genome research.
[27] A. Nicholson,et al. Mutations of the BRAF gene in human cancer , 2002, Nature.
[28] S. Antonarakis,et al. Mutation nomenclature extensions and suggestions to describe complex mutations: A discussion , 2000 .
[29] E Schütz,et al. Application of a thermodynamic nearest-neighbor model to estimate nucleic acid stability and optimize probe design: prediction of melting points of multiple mutations of apolipoprotein B-3500 and factor V with a hybridization probe genotyping assay on the LightCycler. , 1999, Clinical chemistry.
[30] E Schütz,et al. Spreadsheet software for thermodynamic melting point prediction of oligonucleotide hybridization with and without mismatches. , 1999, BioTechniques.
[31] D. Whitcombe,et al. Detection of PCR products using self-probing amplicons and fluorescence , 1999, Nature Biotechnology.
[32] M. Egholm,et al. Sequence-selective recognition of DNA by strand displacement with a thymine-substituted polyamide. , 1991, Science.
[33] C Summers,et al. Analysis of any point mutation in DNA. The amplification refractory mutation system (ARMS). , 1989, Nucleic acids research.